Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism

被引:30
作者
Papandreou, Christopher [1 ,2 ]
Li, Jun [3 ]
Liang, Liming [4 ,5 ]
Bullo, Monica [1 ,2 ]
Zheng, Yan [3 ]
Ruiz-Canela, Miguel [2 ,6 ]
Yu, Edward [3 ]
Guasch-Ferre, Marta [1 ,2 ,3 ]
Razquin, Cristina [2 ,6 ]
Clish, Clary [7 ]
Corella, Dolores [2 ,8 ]
Estruch, Ramon [2 ,9 ]
Ros, Emilio [2 ,10 ]
Fito, Montserrat [2 ,11 ]
Aros, Fernando [2 ,12 ]
Serra-Majem, Lluis [2 ,13 ]
Rosique, Nuria [1 ,2 ]
Martinez-Gonzalez, Miguel A. [2 ,3 ,6 ]
Hu, Frank B. [3 ,4 ,5 ,14 ,15 ]
Salas-Salvado, Jordi [1 ,2 ]
机构
[1] Rovira & Virgili Univ, Inst Invest Sanitaria Pere Virgili, Human Nutr Unit, Fac Med & Hlth Sci, Reus, Spain
[2] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain
[3] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[4] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[5] Harvard TH Chan Sch Publ Hlth, Dept Stat, Boston, MA USA
[6] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain
[7] Broad Inst MIT & Harvard Univ, Cambridge, MA USA
[8] Univ Valencia, Dept Prevent Med, Valencia, Spain
[9] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDI BAPS, Dept Internal Med,Dept Endocrinol & Nutr, Barcelona, Spain
[10] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDI BAPS, Lipid Clin,Dept Endocrinol & Nutr, Barcelona, Spain
[11] Hosp del Mar, Cardiovasc & Nutr Res Grp, Inst Recerca, Barcelona, Spain
[12] Univ Hosp Alava, Dept Cardiol, Vitoria, Spain
[13] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain
[14] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, 75 Francis St, Boston, MA 02115 USA
[15] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
ADENOSINE; ALLANTOIN;
D O I
10.1038/s41598-019-39441-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Studies examining associations between purine metabolites and type 2 diabetes (T2D) are limited. We prospectively examined associations between plasma levels of purine metabolites with T2D risk and the modifying effects of transcription factor-7-like-2 (TCF7L2) rs7903146 polymorphism on these associations. This is a case-cohort design study within the PREDIMED study, with 251 incident T2D cases and a random sample of 694 participants (641 non-cases and 53 overlapping cases) without T2D at baseline (median follow-up: 3.8 years). Metabolites were semi-quantitatively profiled with LC-MS/MS. Cox regression analysis revealed that high plasma allantoin levels, including allantoin-to-uric acid ratio and high xanthine-to-hypoxanthine ratio were inversely and positively associated with T2D risk, respectively, independently of classical risk factors. Elevated plasma xanthine and inosine levels were associated with a higher T2D risk in homozygous carriers of the TCF7L2-rs7903146 T-allele. The potential mechanisms linking the aforementioned purine metabolites and T2D risk must be also further investigated.
引用
收藏
页数:11
相关论文
共 41 条
[11]  
Ekpenyong C., 2014, Am. J. Intern. Med, V2, P113, DOI [10.11648/j.ajim.20140206.15, DOI 10.11648/J.AJIM.20140206.15]
[12]   VALIDATION OF THE MINNESOTA LEISURE-TIME PHYSICAL-ACTIVITY QUESTIONNAIRE IN SPANISH MEN [J].
ELOSUA, R ;
MARRUGAT, J ;
MOLINA, L ;
PONS, S ;
PUJOL, E ;
ARQUER, A ;
COVAS, MI ;
DEFLORES, T ;
FORNELLS, X ;
MARTINEZ, S ;
PEREA, M ;
PUJOL, P ;
RICHART, JA ;
RUBIES, J ;
TOMAS, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (12) :1197-1209
[13]   Homozygous carriers of the TCF7L2 rs7903146 T-allele show altered postprandial response in triglycerides and triglyceride-rich lipoproteins [J].
Engelbrechtsen, L. ;
Hansen, T. H. ;
Mahendran, Y. ;
Pyl, P. ;
Andersson, E. ;
Jonsson, A. ;
Gjesing, A. ;
Linneberg, A. ;
Jorgensen, T. ;
Hansen, T. ;
Vestergaard, H. .
SCIENTIFIC REPORTS, 2017, 7
[14]  
Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1200303, 10.1056/nejmoa1800389, 10.1056/NEJMoa1800389]
[15]   Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test [J].
Gjesing, A. P. ;
Kjems, L. L. ;
Vestmar, M. A. ;
Grarup, N. ;
Linneberg, A. ;
Deacon, C. F. ;
Holst, J. J. ;
Pedersen, O. ;
Hansen, T. .
DIABETOLOGIA, 2011, 54 (01) :103-110
[16]   Antidiabetic Effects of Yam (Dioscorea batatas) and Its Active Constituent, Allantoin, in a Rat Model of Streptozotocin-Induced Diabetes [J].
Go, Hyeon-Kyu ;
Rahman, Md. Mahbubur ;
Kim, Gi-Beum ;
Na, Chong-Sam ;
Song, Choon-Ho ;
Kim, Jin-Shang ;
Kim, Shang-Jin ;
Kang, Hyung-Sub .
Nutrients, 2015, 7 (10) :8532-8544
[17]   Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes [J].
Grant, SFA ;
Thorleifsson, G ;
Reynisdottir, I ;
Benediktsson, R ;
Manolescu, A ;
Sainz, J ;
Helgason, A ;
Stefansson, H ;
Emilsson, V ;
Helgadottir, A ;
Styrkarsdottir, U ;
Magnusson, KP ;
Walters, GB ;
Palsdottir, E ;
Jonsdottir, T ;
Gudmundsdottir, T ;
Gylfason, A ;
Saemundsdottir, J ;
Wilensky, RL ;
Reilly, MP ;
Rader, DJ ;
Bagger, Y ;
Christiansen, C ;
Gudnason, V ;
Sigurdsson, G ;
Thorsteinsdottir, U ;
Gulcher, JR ;
Kong, A ;
Stefansson, K .
NATURE GENETICS, 2006, 38 (03) :320-323
[18]   Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock [J].
Haskó, G ;
Kuhel, DG ;
Németh, ZH ;
Mabley, JG ;
Stachlewitz, RF ;
Virág, L ;
Lohinai, Z ;
Southan, GJ ;
Salzman, AL ;
Szabó, C .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :1013-1019
[19]   Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms [J].
Haskó, G ;
Kuhel, DG ;
Chen, JF ;
Schwarzschild, MA ;
Deitch, EA ;
Mabley, JG ;
Marton, A ;
Szabó, C .
FASEB JOURNAL, 2000, 14 (13) :2065-2074
[20]   Urinary F2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes [J].
Il'yasova, Dora ;
Spasojevic, Ivan ;
Base, Karel ;
Zhang, Haoyue ;
Wang, Frances ;
Young, Sarah P. ;
Millington, David S. ;
D'Agostino, Ralph B., Jr. ;
Wagenknecht, Lynne E. .
DIABETES CARE, 2012, 35 (01) :173-174